Israel Englander Millennium Management
Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
DuPont de Nemours
DD
|
+$1.55B |
| 2 |
Comcast
CMCSA
|
+$449M |
| 3 |
SLB Ltd
SLB
|
+$298M |
| 4 |
Alphabet (Google) Class C
GOOG
|
+$281M |
| 5 |
Qualcomm
QCOM
|
+$228M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$229M |
| 2 |
Sempra
SRE
|
+$192M |
| 3 |
Bausch Health
BHC
|
+$183M |
| 4 |
BNY
Bank of New York Mellon
BNY
|
+$175M |
| 5 |
PepsiCo
PEP
|
+$173M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 12.58% |
| 2 | Energy | 11.62% |
| 3 | Consumer Discretionary | 8.89% |
| 4 | Financials | 8.63% |
| 5 | Technology | 8.43% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2701
Vicor
VICR
$8.9B
| $445K | ﹤0.01% |
43,656
+14,040
| +47% | +$146K |
|
|
SD
2702
DELISTED
SANDRIDGE ENERGY, INC.
SD
| $445K | ﹤0.01% |
1,647,262
-46,835
| -3% | -$24.5K |
|
2703
Gladstone Investment Corp
GAIN
$654M
| $444K | ﹤0.01% |
63,000
-41,471
| -40% | -$319K |
|
|
CAFD
2704
DELISTED
8point3 Energy Partners LP
CAFD
| $443K | ﹤0.01% |
+41,727
| New | +$635K |
|
|
TVIX
2705
DELISTED
VelocityShares Daily 2x VIX Short Term ETN
TVIX
| $443K | ﹤0.01% |
+1
| New | +$234K |
|
2706
Embotelladora Andina Series B
AKO.B
$4.86B
| $441K | ﹤0.01% |
+21,274
| New | +$408K |
|
2707
CorVel
CRVL
$3.52B
| $441K | ﹤0.01% |
40,932
-49,200
| -55% | -$529K |
|
|
HTBK
2708
DELISTED
Heritage Commerce
HTBK
| $441K | ﹤0.01% |
+38,870
| New | +$418K |
|
2709
Federal Agricultural Mortgage
AGM
$2.37B
| $440K | ﹤0.01% |
16,983
+2,150
| +14% | +$56.8K |
|
2710
Hallador Energy
HNRG
$770M
| $440K | ﹤0.01% |
+63,350
| New | +$469K |
|
|
ILG
2711
DELISTED
ILG, Inc Common Stock
ILG
| $440K | ﹤0.01% |
23,954
-164,538
| -87% | -$3.4M |
|
|
SCNB
2712
DELISTED
Suffolk Bancorp
SCNB
| $440K | ﹤0.01% |
+16,091
| New | +$442K |
|
2713
Aecom
ACM
$7.99B
| $439K | ﹤0.01% |
15,973
-28,334
| -64% | -$823K |
|
|
VIVS
2714
VivoSim Labs
VIVS
$3.88M
| $439K | ﹤0.01% |
+682
| New | +$518K |
|
|
ACH
2715
DELISTED
Alum Corp of China Ltd
ACH
| $438K | ﹤0.01% |
+56,426
| New | +$505K |
|
|
KBAL
2716
DELISTED
Kimball International
KBAL
| $435K | ﹤0.01% |
45,962
-106,431
| -70% | -$1.2M |
|
|
CASC
2717
DELISTED
Cascadian Therapeutics, Inc.
CASC
| $434K | ﹤0.01% |
26,417
-35,180
| -57% | -$721K |
|
2718
ESCO Technologies
ESE
$7.18B
| $432K | ﹤0.01% |
+12,040
| New | +$442K |
|
2719
Metallus
MTUS
$794M
| $432K | ﹤0.01% |
42,714
-202,524
| -83% | -$3.66M |
|
|
OTIC
2720
DELISTED
Otonomy, Inc.
OTIC
| $432K | ﹤0.01% |
+24,236
| New | +$573K |
|
|
OLBK
2721
DELISTED
Old Line Bancshares, Inc.
OLBK
| $432K | ﹤0.01% |
26,569
-3,661
| -12% | -$58K |
|
2722
Vaalco Energy
EGY
$603M
| $431K | ﹤0.01% |
253,442
-9,857
| -4% | -$16.2K |
|
|
SPNS
2723
DELISTED
Sapiens International
SPNS
| $431K | ﹤0.01% |
+37,453
| New | +$426K |
|
|
SKUL
2724
DELISTED
SKULLCANDY INC
SKUL
| $431K | ﹤0.01% |
78,000
-35,000
| -31% | -$246K |
|
2725
UMB Financial
UMBF
$10.9B
| $429K | ﹤0.01% |
8,446
-2,704
| -24% | -$143K |
|
Similar funds
Israel Englander's Q3 2015 Portfolio in Review
As of Q3 2015, Israel Englander held 4,098 positions worth $51.6B, down 2.3% from $52.9B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Israel Englander deployed $5.12B of net new capital in Q3 2015, opening 839 new positions and adding to 1,320 existing holdings. Its largest new stake was BP: 4,551,492 shares worth $117M.
By sector, the portfolio is most concentrated in Healthcare at 13% of assets, down from 15% a quarter earlier, followed by Energy and Consumer Discretionary.
On the sell side, the largest reduction was Alexion Pharmaceuticals, an estimated $229M trimmed.
- Israel Englander's largest Q3 2015 buy was BP: 4,551,492 shares worth $117M.
- Israel Englander added most to DuPont de Nemours in Q3 2015, an estimated $1.55B increase.
- Israel Englander's biggest Q3 2015 reduction was Alexion Pharmaceuticals, cutting an estimated $229M.
- Israel Englander fully exited PepsiCo in Q3 2015, selling an estimated $173M.
- Israel Englander's ten largest holdings make up 14% of its $51.6B portfolio in Q3 2015.
- Israel Englander opened 839 new positions and closed 681 in Q3 2015.
- Israel Englander's portfolio value fell 2.3% quarter-over-quarter to $51.6B.
Based on Millennium Management's 13F filing for Q3 2015, filed 16 Nov 2015.